Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
This explanation clarifies What Is A Market Benchmark Index, its uses in breadth assessment, and how to apply it in portfolios.
27,218 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A growing share of Americans near retirement have roughly $500K saved, but rising healthcare costs and longer lifespa...
Weekly pending home sales return to year-over-year growth as spring approaches, with 2026 readings pointing to renewe...
Federal Reserve officials weighed the strength of the labor market as January payrolls edge higher, creating a tense ...
When NVIDIA reports earnings on Feb. 25, investors will scan every line for AI demand signals, margin trends, and gui...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
When a member of the texas capital bancshares board makes a sizable purchase, it often prompts questions from investo...
NVIDIA is signaling a bold push into faster AI inference with a new chip design. This move could reshape cloud comput...
Online mattress sales surge in 2026 as shoppers chase value, comfort, and easy returns. This report outlines the tren...
A potential new Fed chair could push for an early rate cut, but escalating Middle East tensions threaten to keep poli...